Sobre
Dr Mubarak Almansour is a highly qualified Consultant Medical Oncologist and Associate Professor, recognised for their expertise in the diagnosis and management of complex cancer cases. With a patient-centred approach to care, Dr Almansour combines clinical excellence with a strong academic background, ensuring that patients receive treatment based on the latest medical evidence. They are dedicated to providing comprehensive oncology care, guiding patients through their treatment journeys with compassion and professional rigour.
Dr Almansour’s extensive medical training was completed at world-renowned institutions in North America. After obtaining their medical degree from King Abdulaziz University, they pursued postgraduate training at the University of British Columbia in Canada. There, they completed a residency in Internal Medicine followed by two specialised fellowships at the British Columbia Cancer Agency: one in Medical Oncology and a second sub-specialty fellowship dedicated to Lymphoma. They hold quadruple board certifications, having achieved the American Board and Canadian Board certifications in both Internal Medicine and Medical Oncology.
In addition to their clinical practice, Dr Almansour is an active leader in the medical community and a key contributor to oncology research. They have played a pivotal role in establishing international conferences and serve on scientific committees dedicated to advancing cancer treatment. Their clinical focus encompasses a broad range of adult malignancies, with specific sub-specialty interest in lymphoid malignancies and genitourinary tumours.
Dr Almansour’s extensive medical training was completed at world-renowned institutions in North America. After obtaining their medical degree from King Abdulaziz University, they pursued postgraduate training at the University of British Columbia in Canada. There, they completed a residency in Internal Medicine followed by two specialised fellowships at the British Columbia Cancer Agency: one in Medical Oncology and a second sub-specialty fellowship dedicated to Lymphoma. They hold quadruple board certifications, having achieved the American Board and Canadian Board certifications in both Internal Medicine and Medical Oncology.
In addition to their clinical practice, Dr Almansour is an active leader in the medical community and a key contributor to oncology research. They have played a pivotal role in establishing international conferences and serve on scientific committees dedicated to advancing cancer treatment. Their clinical focus encompasses a broad range of adult malignancies, with specific sub-specialty interest in lymphoid malignancies and genitourinary tumours.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mubarak Almansour
Educação e formação
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Oncologia
-
2021–2022 Fellowship · Subspecialty training
Carreira e nomeações
-
2021-09–2022-08 Junior consultant
Licenças e seguros
Licenças médicas
SA — Organización Médica Colegial de España (OMC)
Certificações do conselho
European Board of Oncologia
Seguro de responsabilidade profissional:
Generali Healthcare · 3,000,000 EUR cobertura · No claims on file
Procedimentos realizados
| Procedimento | Código | Total acumulado |
|---|---|---|
| GP consultation | 99213 | 1,636 |
| Annual physical exam | 99395 | 1,442 |
| Vaccination administration | 90471 | 1,370 |
| Minor procedure (skin) | 17110 | 1,605 |
Serviços e preços
| Serviço | Duração | Modalidade | Preço |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 720.00 EUR |
Consultório, equipa e na prática
Vídeos
Investigação e publicações
índice h: 17 · i10: 10
-
European registry analysis of Oncologia outcomes
DOI: 10.6789/euroclin.2025.0 · PMID: 32497645 · citado por 84
-
Outcomes of Oncologia in adults — a multi-centre cohort
DOI: 10.2529/euroclin.2024.1 · PMID: 37582222 · citado por 6
-
European registry analysis of Oncologia outcomes
DOI: 10.7214/euroclin.2023.2 · PMID: 36115057 · citado por 144
-
Outcomes of Oncologia in adults — a multi-centre cohort
DOI: 10.5013/euroclin.2022.3 · PMID: 31578989 · citado por 42
Palestras convidadas
- Practical updates in Oncologia European Annual Congress (Oncologia) · Vienna · 2024 · invited
- Single-centre experience in Oncologia National Society Meeting · Riyadh · 2023 · oral abstract
Prémios e afiliações
Prémios
- 🏆 Top-rated Oncologia — Riyadh · EuroClinics Patient Choice · 2025 · regional
Filiações em sociedades
- WONCA Europe — Family Doctors — Member · Desde 2022
- national college of family doctors — Member · Desde 2022
- European Union of Medical Specialists (UEMS) — Member · Desde 2022
Artigos deste médico
- Patient education Patient guide to Oncologia
- Awareness When should you see a oncologia?
Para pacientes internacionais
- Coordenador
- Patient liaison · mubarak.almansour@euroclinics.example
Localização
1 etiquetaAvaliações dos pacientes
Partilhe a sua experiência — ajude outros pacientes a encontrar o médico certo. Escrever uma avaliação →
Avaliações recentes
-
★★★★★ ✓ Verificado Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificado Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificado Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.